高同型半胱氨酸血症与心血管事件

[1] Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration [J]. CIRCULATION RESEARCH, 2008, 102 (12) : 1529 - 1538

[2] Relation between plasma homocysteine, gene polymorphisms of homocysteine metabolism-related enzymes, and angiographically proven coronary artery disease[J] . Abdelilah Laraqui,Abdellatif Allami,Alain Carrié,Alain Raisonnier,Anne-Sofie Coiffard,Fatima Benkouka,Abdenabi Bendriss,Abdelaziz Benjouad,N. Bennouar,Nizar El Kadiri,Anwar Benomar,Seddik Fellat,Mohamed Benomar.European Journal of Internal Medicine . 2007 (6)

[3] Do Diet, Folic Acid, and Vitamins Matter?: What Did We Learn From The Women?s Health Initiative, The Women?s Health Study, The Women?s Antioxidant and Folic Acid Cardiovascular Study, and Other Clinical Trials?[J] . Nanette K. Wenger.Cardiology in Review . 2007 (6)

[4] Study of the effectiveness of additional reductions in cholesterol and homocysteine （SEARCH）: Characteristics of a randomized trial among 12＜ce:hsp sp="0.12"/＞064 myocardial infarction survivors[J] . American Heart Journal . 2007 (5)

[5] Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease [J]. JOURNAL OF INTERNAL MEDICINE, 2007, 262 (02) : 244 - 253

[6] Homocysteine and stroke [J]. LANCET, 2005, 365 (9455) : 194 - 196

[7] Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus （the FIELD study）: randomised controlled trial[J] . Keech A,Simes R J,Barter P,Best J,Scott R,Taskinen M R,Forder P,Pillai A,Davis T,Glasziou P,Drury P,Kes?niemi Y A,Sullivan D,Hunt D,Colman P,d"Emden M,Whiting M,Ehnholm C,Laakso M.The Lancet . 2005 (9500)

[8] The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels[J] . Dierkes,Westphal,Luley.Expert Opinion on Drug Safety . 2004 (2)

[1] Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration [J]. CIRCULATION RESEARCH, 2008, 102 (12) : 1529 - 1538

[2] Relation between plasma homocysteine, gene polymorphisms of homocysteine metabolism-related enzymes, and angiographically proven coronary artery disease[J] . Abdelilah Laraqui,Abdellatif Allami,Alain Carrié,Alain Raisonnier,Anne-Sofie Coiffard,Fatima Benkouka,Abdenabi Bendriss,Abdelaziz Benjouad,N. Bennouar,Nizar El Kadiri,Anwar Benomar,Seddik Fellat,Mohamed Benomar.European Journal of Internal Medicine . 2007 (6)

[3] Do Diet, Folic Acid, and Vitamins Matter?: What Did We Learn From The Women?s Health Initiative, The Women?s Health Study, The Women?s Antioxidant and Folic Acid Cardiovascular Study, and Other Clinical Trials?[J] . Nanette K. Wenger.Cardiology in Review . 2007 (6)

[4] Study of the effectiveness of additional reductions in cholesterol and homocysteine （SEARCH）: Characteristics of a randomized trial among 12＜ce:hsp sp="0.12"/＞064 myocardial infarction survivors[J] . American Heart Journal . 2007 (5)

[5] Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease [J]. JOURNAL OF INTERNAL MEDICINE, 2007, 262 (02) : 244 - 253

[6] Homocysteine and stroke [J]. LANCET, 2005, 365 (9455) : 194 - 196

[7] Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus （the FIELD study）: randomised controlled trial[J] . Keech A,Simes R J,Barter P,Best J,Scott R,Taskinen M R,Forder P,Pillai A,Davis T,Glasziou P,Drury P,Kes?niemi Y A,Sullivan D,Hunt D,Colman P,d"Emden M,Whiting M,Ehnholm C,Laakso M.The Lancet . 2005 (9500)

[8] The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels[J] . Dierkes,Westphal,Luley.Expert Opinion on Drug Safety . 2004 (2)